GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
E

EKF Diagnostics Holdings EKF.L · GBp

Health Care · LSE · 🇬🇧 United Kingdom

Compare

24.40p

0.00%

Close of 9 Nov 2026, in pence

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in GBP, from our data supplier.

FY2025

Revenue

£51.6m

FY2016FY2025

Net income

£2.1m

FY2016FY2025

Free cash flow

£8.2m

FY2016FY2025

Shareholders' equity

£69.0m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue£51.6m£50.2m£52.6m£66.6m£81.8m£65.3m£44.9m£42.5m£41.6m£38.6m
Gross profit£26.5m£21.5m£23.9m£24.0m£39.4m£37.4m£23.7m£22.7m£22.9m£18.3m
Research and development£1.4m£1.3m£1.8m£1.5m£1.4m£1.4m£2.3m£1.6m£2.2m£2.0m
Operating income£7.0m£6.5m£2.1m£7.6m£21.7m£16.9m£5.8m£12.2m£4.7m−£327,000
Net income£2.1m£6.2m£2.4m−£10.1m£15.9m£11.1m£3.7m£10.1m£2.7m−£18,000
Diluted earnings per share0.000.010.01-0.020.030.020.010.020.01-0.00

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets£81.1m£81.7m£80.8m£89.3m£115.1m£101.3m£87.1m£81.4m£77.2m£82.4m
Cash and short-term investments£15.8m£13.0m£6.0m£11.6m£20.3m£21.9m£12.1m£10.3m£8.2m£7.9m
Total liabilities£10.9m£8.5m£12.6m£14.8m£20.4m£23.1m£16.0m£17.5m£16.7m£21.5m
Debt£1.4m£1.3m£4.1m£1.5m£3.5m£2.0m£1.7m£880,000£1.2m£5.7m
Shareholders' equity£69.0m£72.3m£67.1m£73.3m£94.1m£77.6m£70.6m£63.5m£60.0m£60.5m
Shares outstanding448m454m454m455m464m459m458m458m461m469m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations£9.7m£13.7m£6.3m£9.7m£10.2m£13.8m£5.1m£8.3m£9.1m£8.9m
Capital spending−£1.5m−£2.2m−£7.0m−£5.8m−£5.6m−£2.6m−£2.4m−£1.9m−£2.2m−£1.9m
Free cash flow£8.2m£11.4m−£664,000£3.9m£4.6m£11.2m£2.7m£6.5m£6.8m£7.0m
Dividends paid——−£5.4m−£5.5m−£5.1m−£4.5m−£15,000−£4.5m−£4.5m—

Latest quarters

By quarter end

Jun 2026Dec 2025Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022
Revenue£25.0m£26.3m£25.2m£25.0m£25.2m£25.7m£26.9m£29.2m
Gross profit£13.3m£13.8m£12.7m£12.3m£12.1m£12.4m£12.0m£13.1m
Operating income£3.5m£3.3m£3.5m£3.4m£2.9m£3.7m£1.1m£2.7m
Net income£2.3m£178,000£1.9m£4.2m£2.1m£2.7m−£358,000−£12.3m
Diluted earnings per share0.010.000.000.010.000.01-0.00-0.03
Cash from operations£3.0m£4.0m£4.0m£5.0m£7.0m£3.0m£2.0m£1.0m
Capital spending—−£1.0m——−£1.0m−£3.0m−£3.0m−£2.0m
Free cash flow—£3.0m——£6.0m£0−£1.0m−£1.0m
Total assets£82.3m£81.1m£82.4m£81.7m£79.3m£80.8m£82.3m£89.3m
Cash and short-term investments£16.0m£15.8m£16.6m£13.0m£9.8m£7.7m£9.2m£11.6m
Debt£337,000£398,000£208,000£420,000£237,000£3.5m£444,000£1.0m
Shareholders' equity£70.4m£69.0m£71.7m£72.3m£68.8m£67.1m£64.2m£73.3m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-8.2%-4.6%5.5%
Operating income-2.7%-16.2%—
Net income—-28.2%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin47.1%43.4%46.9%48.6%
Operating margin13.2%10.4%16.8%12.3%
Net margin8.2%0.3%7.5%1.2%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings55.919.661.1-22.521.729.642.712.444.6-4465.3
Price to sales2.32.42.73.44.25.03.52.92.92.1

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 2 Nov 2023.

FY2023FY2022FY2021FY2020
Paid in the year0.0120.0120.0110.01

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.